Non Human Primate Models of SIV and HIV Immune Protection
$330,803ZIAFY2015AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications & trials
Paper 27120156Paper 26998834Paper 26581981Paper 25787288Paper 25142607Paper 25119033Paper 24990883Paper 22647691Paper 22593152Paper 22532675Paper 22521913Paper 21775457Paper 21593181Paper 21543722Paper 21450829Paper 21379569Paper 20667574Paper 19906933Paper 19656883Paper 19640980Paper 19591571Paper 19550289Paper 19414559Paper 15613305
Abstract
Antibodies against HIV are potential drugs that may be able to prevent HIV infection in humans. However, the long-term protective capacity of antibodies against HIV has not been assessed. In this study, we repetitively administered a macaque version of a human anti-HIV antibody to monkeys, after which the antibody persisted in the blood for >5 months. Moreover, the antibody could be sustained at protective levels for 108 days, conferring protection 52 days after the last dose in a monkey model of HIV infection. Thus, passive antibody transfer can provide durable protection against infection by viruses that cause AIDS in primates.
View original record on NIH RePORTER →